We are live on ! Find out more
IUHSA

Itau Unibanco Holding S.A. Portfolio holdings

AUM $4.31B
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+46.57%
3 Year Est. Return
+107.3%
5 Year Est. Return
+125.12%
10 Year Est. Return
+406.64%
AUM
$2.21B
AUM Growth
+$455M
Cap. Flow
+$471M
Cap. Flow %
21.31%
Top 10 Hldgs %
57.45%
Holding
728
New
140
Increased
204
Reduced
231
Closed
141

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$86.7M
2
AAPL icon
Apple
AAPL
+$18.9M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$12M
4
TV icon
Televisa
TV
+$11.3M
5
CX icon
Cemex
CX
+$8.09M

Sector Composition

Rank Sector Weight
1 Financials 19.99%
2 Energy 8.67%
3 Communication Services 8.21%
4 Materials 4.73%
5 Industrials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALA icon
576
KALA BIO
KALA
$14.5M
$8K ﹤0.01%
1
LQD icon
577
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$8K ﹤0.01%
75
-17,200
-100% -$1.93M
RIGL icon
578
Rigel Pharmaceuticals
RIGL
$750M
$8K ﹤0.01%
338
-26
-7% -$734
KDNY
579
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$8K ﹤0.01%
600
-46
-7% -$919
OTIC
580
DELISTED
Otonomy, Inc.
OTIC
$5K ﹤0.01%
2,674
-531
-17% -$1.25K
FE icon
581
FirstEnergy
FE
$27.5B
$4K ﹤0.01%
+100
New +$3.79K
CALA
582
DELISTED
Calithera Biosciences, Inc
CALA
$4K ﹤0.01%
56
-15
-21% -$1.48K
TRVN
583
DELISTED
Trevena, Inc.
TRVN
$3K ﹤0.01%
10
JNCE
584
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3K ﹤0.01%
841
+53
+7% +$248
FPRX
585
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3K ﹤0.01%
300
-298
-50% -$3.55K
CLSD
586
DELISTED
Clearside Biomedical
CLSD
$1K ﹤0.01%
52
+6
+13% +$282
NTGN
587
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$1K ﹤0.01%
309
+58
+23% +$406
ABBV icon
588
AbbVie
ABBV
$435B
-2,103
Closed -$199K
ABG icon
589
Asbury Automotive
ABG
$3.85B
-1,677
Closed -$115K
ACLS icon
590
Axcelis
ACLS
$4.33B
-3,357
Closed -$66K
AEIS icon
591
Advanced Energy
AEIS
$13B
-1,216
Closed -$63K
ALG icon
592
Alamo Group
ALG
$2.05B
-1,562
Closed -$143K
AMAT icon
593
Applied Materials
AMAT
$428B
-4,189
Closed -$162K
AMN icon
594
AMN Healthcare
AMN
$1.4B
-2,743
Closed -$150K
ANF icon
595
Abercrombie & Fitch
ANF
$5B
-4,304
Closed -$91K
ANIK icon
596
Anika Therapeutics
ANIK
$287M
-2,761
Closed -$116K
APEI icon
597
American Public Education
APEI
$940M
-3,155
Closed -$104K
ASIX icon
598
AdvanSix
ASIX
$444M
-2,713
Closed -$92K
OPTU
599
Optimum Communications Inc
OPTU
$301M
-21,351
Closed -$387K
AVNT icon
600
Avient
AVNT
$4.19B
-4,823
Closed -$211K

Similar funds

Itau Unibanco Holding S.A.'s Q4 2018 Portfolio in Review

As of Q4 2018, Itau Unibanco Holding S.A. held 728 positions worth $2.21B, up 26% from $1.76B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Itau Unibanco Holding S.A. deployed $471M of net new capital in Q4 2018, opening 140 new positions and adding to 204 existing holdings. Its largest new stake was Alphabet (Google) Class C: 2,000,000 shares worth $104M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $86.7M trimmed.

  • Itau Unibanco Holding S.A.'s largest Q4 2018 buy was Alphabet (Google) Class C: 2,000,000 shares worth $104M.
  • Itau Unibanco Holding S.A. added most to iShares MSCI Japan ETF in Q4 2018, an estimated $90.8M increase.
  • Itau Unibanco Holding S.A.'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $86.7M.
  • Itau Unibanco Holding S.A. fully exited Televisa in Q4 2018, selling an estimated $11.3M.
  • Itau Unibanco Holding S.A.'s ten largest holdings make up 57% of its $2.21B portfolio in Q4 2018.
  • Itau Unibanco Holding S.A. opened 140 new positions and closed 141 in Q4 2018.
  • Itau Unibanco Holding S.A.'s portfolio value rose 26% quarter-over-quarter to $2.21B.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2018, filed 13 Feb 2019.